- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05186194
The Effect of Vitamin D and Calcium Supplementation on the Prevention of Stress Fractures.
December 22, 2021 updated by: Xijing Hospital
The Effect of Vitamin D and Calcium Supplementation on the Prevention of Stress Fractures in Chinese Recruits.
The main objective of this study is to find whether supplemental vitamin d and calcium can reduce the incidence of stress fractures in recruits.
These high-risk recruits undergo intensive training which elevated bone turnover, which requires adequate level of vitamin D and calcium in order to support bone health.
It is hypothesized that supplemental vitamin d and calcium will decrease the occurrence of stress fractures.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
240
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: long bi, MD,PHD
- Phone Number: +86 02984773524
- Email: bilong@fmmu.edu.cn
Study Locations
-
-
Shanxi
-
Xi'an, Shanxi, China, 710032
- Recruiting
- Department of Orthopedics, Xijing Hospital, The Air Force Medical University
-
Contact:
- long bi, MD,PHD
- Phone Number: +86 02984773524
- Email: bilong@fmmu.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 25 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Recruits newly enlisted at a training base in September 2021.
- Agree to accept relevant inspections and serological research, and sign an informed consent form.
Exclusion Criteria:
- Suffer from diabetes, osteomyelitis and other diseases.
- Suffer from claustrophobia and other MRI examination contraindications.
- Long-term use of glucocorticoids, non-steroidal anti-inflammatory drugs or calcium, vitamin D.
- A history of kidney disease.
- Allergic to any ingredient of the medicine.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental (Treatment) Group
Oral vitamin D1000IU, 1/day, calcium 1200mg, 1/day, for 8 weeks.
|
Vitamin D, calcium are available in tablets.
During the 8 weeks of training, subjects were asked to take supplement tablets per day after dinner.
|
|
Placebo Comparator: Control Group
Oral placebo, for 8 weeks.
|
Placebo
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stress fracture
Time Frame: 3 months after the start of the basic military training.
|
Stress fractures were recorded when recruits reported to the clinic with suspected symptoms.
All stress fractures were confirmed with radiography or Magnetic Resonance Imaging(MRI).
Each subject with a stress fracture was recorded.
|
3 months after the start of the basic military training.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 30, 2021
Primary Completion (Anticipated)
June 30, 2022
Study Completion (Anticipated)
September 30, 2022
Study Registration Dates
First Submitted
December 8, 2021
First Submitted That Met QC Criteria
December 22, 2021
First Posted (Actual)
January 11, 2022
Study Record Updates
Last Update Posted (Actual)
January 11, 2022
Last Update Submitted That Met QC Criteria
December 22, 2021
Last Verified
December 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KY20212116-F-2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress Fracture
-
Balgrist University HospitalRecruitingStress Fracture Metatarsal | Lower Limb Fracture | Stress Fracture Foot | Stress Fracture Ankle | Stress Fracture of TibiaSwitzerland
-
Oslo University HospitalSykehuset Ostfold; Betanien HospitalTerminatedStress Fracture Foot | Stress Fracture AnkleNorway
-
Brooke Army Medical CenterUniformed Services University of the Health Sciences; The Geneva FoundationCompletedMetatarsal Stress Fracture | Stress Fracture of TibiaUnited States
-
University of Central LancashireCompletedTibial Stress Fracture
-
Fundación Garcia CugatCompletedEffectiveness of Shockwave Treatment for Proximal Fifth Metatarsal Stress Fracture in Soccer PlayersStress Fracture MetatarsalSpain
-
Zimmer BiometCompletedStress Fracture | Insufficiency Fractures | Stress Fracture, Ankle, Foot and ToesUnited States, Canada
-
University of South CarolinaUnited States Department of Defense; Eisenhower Army Medical Center; Moncrief...Enrolling by invitationStress Fracture of Tibia or FibulaUnited States
-
University of South CarolinaWashington University School of MedicineNot yet recruitingStress Fracture | Fracture Healing | Military TrainingUnited States
-
Creighton UniversityGlaxoSmithKline; United States Department of DefenseCompletedStress FractureUnited States
-
University of East AngliaMinistry of Defence, United Kingdom; Clinical Research and Trials Unit (Norfolk... and other collaboratorsUnknownStress Fracture | Parathyroid HormoneUnited Kingdom
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
AkesoNot yet recruitingAtopic DermatitisChina
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of